Lv2
132 积分 2024-03-06 加入
[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
3天前
已完结
Surufatinib combined with sintilimab and IBI310 for the treatment of high‐grade advanced‐neuroendocrine neoplasms: A single arm, open‐label, single‐center, phase II study
3天前
已完结
[Expert consensus on the treatment of chronic rhinosinusitis with nasal polyps with biologics (2025)]
4天前
已完结
STING reprogramming by estrogen promotes neutrophil extracellular trap formation and sex-biased resistance to ADC therapy
5天前
已完结
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
14天前
已完结
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1个月前
已完结
Novel asthma treatments
2个月前
已关闭
Novel asthma treatments
2个月前
已完结
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
2个月前
已完结
Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma
2个月前
已完结
皖公网安备34019202002308
